|
|
||||||||
/
) mice and
intestinal inflammation*
DNAX Research Institute of Cellular and Molecular Biology, Palo Alto, California 94304
Interleukin
(IL)-10
/
mice
spontaneously develop intestinal inflammation characterized by
discontinuous transmural lesions affecting the small and large
intestine and by dysregulated production of proinflammatory cytokines.
The uncontrolled generation of IFN-
-producing CD4+ T
cells (Th1 type) has been shown to play a causal role in the development of enterocolitis affecting these mutants. This article discusses studies of
IL-10
/
mice that have
investigated the role of enteric organisms in triggering intestinal
disease, the mediators responsible for initiating and maintaining
intestinal disease, the role IL-10 plays in the generation and/or
function of regulatory cells, and the results of IL-10 therapy in
experimental animal models of inflammatory bowel disease (IBD) and
human patients with IBD.
interleukin; counterregulation by IL-10; proinflammatory cytokines; Th1-mediated intestinal disease; IL-10 therapy
This article has been cited by other articles:
![]() |
J. Song, C. Matsuda, Y. Kai, T. Nishida, K. Nakajima, T. Mizushima, M. Kinoshita, T. Yasue, Y. Sawa, and T. Ito A Novel Sphingosine 1-Phosphate Receptor Agonist, 2-Amino-2-propanediol Hydrochloride (KRP-203), Regulates Chronic Colitis in Interleukin-10 Gene-Deficient Mice J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 276 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Setiawan, A. Metwali, A. M. Blum, M. N. Ince, J. F. Urban Jr., D. E. Elliott, and J. V. Weinstock Heligmosomoides polygyrus Promotes Regulatory T-Cell Cytokine Production in the Murine Normal Distal Intestine Infect. Immun., September 1, 2007; 75(9): 4655 - 4663. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Etling, S. Davies, M. Campbell, R. W. Redline, P. Fu, and A. D. Levine Maturation of the mucosal immune system underlies colitis susceptibility in interleukin-10-deficient (IL-10 / ) mice J. Leukoc. Biol., August 1, 2007; 82(2): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dotan, M. Allez, A. Nakazawa, J. Brimnes, M. Schulder-Katz, and L. Mayer Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-{gamma} Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1630 - G1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Chapkin, L. A. Davidson, L. Ly, B. R. Weeks, J. R. Lupton, and D. N. McMurray Immunomodulatory Effects of (n-3) Fatty Acids: Putative Link to Inflammation and Colon Cancer J. Nutr., January 1, 2007; 137(1): 200S - 204S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Overhaus, B. A. Moore, J. E. Barbato, F. F. Behrendt, J. G. Doering, and A. J. Bauer Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G695 - G703. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hernandez, S. Arora, J. R. Erb-Downward, R. A. McDonald, G. B. Toews, and G. B. Huffnagle Distinct Roles for IL-4 and IL-10 in Regulating T2 Immunity during Allergic Bronchopulmonary Mycosis J. Immunol., January 15, 2005; 174(2): 1027 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Mannon, I. J. Fuss, L. Mayer, C. O. Elson, W. J. Sandborn, D. Present, B. Dolin, N. Goodman, C. Groden, R. L. Hornung, et al. Anti-Interleukin-12 Antibody for Active Crohn's Disease N. Engl. J. Med., November 11, 2004; 351(20): 2069 - 2079. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Siegmund, J. A. Sennello, H. A. Lehr, A. Batra, I. Fedke, M. Zeitz, and G. Fantuzzi Development of intestinal inflammation in double IL-10- and leptin-deficient mice J. Leukoc. Biol., October 1, 2004; 76(4): 782 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Blum, A. Metwali, D. E. Elliott, D. J. Berg, and J. V. Weinstock CD4+ T cells from IL-10-deficient mice transfer susceptibility to NSAID-induced Rag colitis Am J Physiol Gastrointest Liver Physiol, August 1, 2004; 287(2): G320 - G325. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Oz, M. Ray, T. S. Chen, and C. J. McClain Efficacy of a Transforming Growth Factor {beta}2 Containing Nutritional Support Formula in a Murine Model of Inflammatory Bowel Disease J. Am. Coll. Nutr., June 1, 2004; 23(3): 220 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Sheil, J McCarthy, L O'Mahony, M W Bennett, P Ryan, J J Fitzgibbon, B Kiely, J K Collins, and F Shanahan Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis Gut, May 1, 2004; 53(5): 694 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
J V Weinstock, R Summers, and D E Elliott Helminths and harmony Gut, January 1, 2004; 53(1): 7 - 9. [Full Text] |
||||
![]() |
S. E. Erdman, V. P. Rao, T. Poutahidis, M. M. Ihrig, Z. Ge, Y. Feng, M. Tomczak, A. B. Rogers, B. H. Horwitz, and J. G. Fox CD4+CD25+ Regulatory Lymphocytes Require Interleukin 10 to Interrupt Colon Carcinogenesis in Mice Cancer Res., September 15, 2003; 63(18): 6042 - 6050. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asadullah, W. Sterry, and H. D. Volk Interleukin-10 Therapy--Review of a New Approach Pharmacol. Rev., June 1, 2003; 55(2): 241 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Erdman, T. Poutahidis, M. Tomczak, A. B. Rogers, K. Cormier, B. Plank, B. H. Horwitz, and J. G. Fox CD4+ CD25+ Regulatory T Lymphocytes Inhibit Microbially Induced Colon Cancer in Rag2-Deficient Mice Am. J. Pathol., February 1, 2003; 162(2): 691 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Wille, E. N. Villegas, L. Craig, R. Peach, and C. A. Hunter Contribution of Interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 Ligand Pathways to the Development of a Pathological T-Cell Response in IL-10-Deficient Mice Infect. Immun., December 1, 2002; 70(12): 6940 - 6947. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Herfarth and J Scholmerich IL-10 therapy in Crohn's disease: at the crossroads Gut, February 1, 2002; 50(2): 146 - 147. [Full Text] [PDF] |
||||
![]() |
L. Maggio-Price, D. Shows, K. Waggie, A. Burich, W. Zeng, S. Escobar, P. Morrissey, and J. L. Viney Helicobacter bilis Infection Accelerates and H. hepaticus Infection Delays the Development of Colitis in Multiple Drug Resistance-Deficient (mdr1a-/-) Mice Am. J. Pathol., February 1, 2002; 160(2): 739 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Eckmann and F. D. Gillin Microbes and Microbial Toxins: Paradigms for Microbial- Mucosal Interactions I. Pathophysiological aspects of enteric infections with the lumen-dwelling protozoan pathogen Giardia lamblia Am J Physiol Gastrointest Liver Physiol, January 1, 2001; 280(1): G1 - G6. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |